RED-CELL NA+/LI+ COUNTERTRANSPORT IN NON-INSULIN-DEPENDENT DIABETICS WITH DIABETIC NEPHROPATHY

Genetic predisposition to essential hypertension, as indicated by increased maximal velocity of Na+/Li+ countertransport in red cells, has been suggested as a marker for the risk of developing diabetic nephropathy. To evaluate the validity of this concept in non-insulin-dependent diabetics, we measured the maximal velocity of Na+/Li+ countertransport in red cells in 18 male diabetics suffering from proteinuria due to biopsy proven diabetic glomerulosclerosis (GFR: 51 [range 27 to 146] ml/min/1.73 m2), 17 male diabetics with normoalbuminuria, and in 18 sex-, age-, and body mass index-matched healthy control subjects. Na+/Li+ countertransport was identical in patients with and without diabetic nephropathy, 0.43 (0.24 to 0.92) versus 0.44 (0.20 to 0.83) mmol/diter cells × hr), but was elevated compared to control subjects, 0.32 (0.09 to 0.73; P < 0.05). Arterial blood pressure was elevated in patients with nephropathy (162/92 ± 21/9 mm Hg) compared to normoalbuminuric patients (132/82 ± 15/7) and control subjects (133/83 ± 14/7 mm Hg; P < 0.001). Our study does not support the hypothesis that the risk of diabetic nephropathy in non-insulin-dependent diabetes is associated with a genetic predisposition to hypertension. Diabetes per se seems to enhance Na+/Li+ countertransport activity.